Hofbauer LC, Busse B, Eastell R, Ferrari S, Frost M, Muller R, Burden AM, Rivadeneira F, Napoli N, Rauner M (2022) Bone fragility in diabetes: novel concepts and clinical implications. Lancet Diab Endocrinol 10:207–220

Article  Google Scholar 

Palui R, Pramanik S, Mondal S, Ray S (2021) Critical review of bone health, fracture risk and management of bone fragility in diabetes mellitus. World J Diab 12:706–729

Article  Google Scholar 

Hunt HB, Torres AM, Palomino PM, Marty E, Saiyed R, Cohn M, Jo J, Warner S, Sroga GE, King KB, Lane JM, Vashishth D, Hernandez CJ, Donnelly E (2019) Altered tissue composition, microarchitecture, and mechanical performance in cancellous bone from men With Type 2 diabetes mellitus. J Bone Miner Res 34:1191–1206

Article  PubMed  CAS  Google Scholar 

Hunt HB, Miller NA, Hemmerling KJ, Koga M, Lopez KA, Taylor EA, Sellmeyer DE, Moseley KF, Donnelly E (2021) Bone tissue composition in postmenopausal women varies with glycemic control from normal glucose tolerance to type 2 diabetes mellitus. J Bone Miner Res 36:334–346

Article  PubMed  CAS  Google Scholar 

Greenblatt MB, Tsai JN, Wein MN (2017) Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clin Chem 63:464–474

Article  PubMed  CAS  Google Scholar 

Shanbhogue VV, Mitchell DM, Rosen CJ, Bouxsein ML (2016) Type 2 diabetes and the skeleton: new insights into sweet bones. Lancet Diab Endocrinol 4:159–173

Article  CAS  Google Scholar 

Sheu A, Greenfield JR, White CP, Center JR (2023) Contributors to impaired bone health in type 2 diabetes. Trends Endocrinol Metab 34:34–48

Article  PubMed  CAS  Google Scholar 

Teissier T, Temkin V, Pollak RD, Cox LS (2022) Crosstalk between senescent bone cells and the bone tissue microenvironment influences bone fragility during chronological age and in diabetes. Front Physiol 13:812157

Article  PubMed  PubMed Central  Google Scholar 

Schwartz AV, Garnero P, Hillier TA, Sellmeyer DE, Strotmeyer ES, Feingold KR, Resnick HE, Tylavsky FA, Black DM, Cummings SR, Harris TB, Bauer DC, Health A, Body Composition S (2009) Pentosidine and increased fracture risk in older adults with type 2 diabetes. J Clin Endocrinol Metab 94:2380–2386

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yamamoto M, Yamaguchi T, Yamauchi M, Yano S, Sugimoto T (2008) Serum pentosidine levels are positively associated with the presence of vertebral fractures in postmenopausal women with type 2 diabetes. J Clin Endocrinol Metab 93:1013–1019

Article  PubMed  CAS  Google Scholar 

Vashishth D (2009) Advanced glycation end-products and bone fractures. IBMS BoneKey 6:268–278

Article  PubMed  PubMed Central  Google Scholar 

Karim L, Moulton J, Van Vliet M, Velie K, Robbins A, Malekipour F, Abdeen A, Ayres D, Bouxsein ML (2018) Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes. Bone 114:32–39

Article  PubMed  PubMed Central  CAS  Google Scholar 

Saito M, Marumo K (2010) Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int 21:195–214

Article  PubMed  CAS  Google Scholar 

Taneda S, Monnier VM (1994) ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin Chem 40:1766–1773

Article  PubMed  CAS  Google Scholar 

Garnero P (2012) The contribution of collagen crosslinks to bone strength. BoneKEy reports 1:18216

Article  Google Scholar 

Sugiyama S, Miyata T, Ueda Y, Tanaka H, Maeda K, Kawashima S, Van Y, persele de Strihou C, Kurokawa K (1998) Plasma levels of pentosidine in diabetic patients: an advanced glycation end product. J Am Soc Nephrol 9:1681–1688

Article  PubMed  CAS  Google Scholar 

Takahashi M, Kushida K, Kawana K, Ishihara C, Denda M, Inoue T, Horiuchi K (1993) Quantification of the cross-link pentosidine in serum from normal and uremic subjects. Clin Chem 39:2162–2165

Article  PubMed  CAS  Google Scholar 

Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Yano S, Sugimoto T (2009) Relationships between serum adiponectin levels versus bone mineral density, bone metabolic markers, and vertebral fractures in type 2 diabetes mellitus. Eur J Endocrinol 160:265–273

Article  PubMed  CAS  Google Scholar 

Shiraki M, Kuroda T, Tanaka S, Saito M, Fukunaga M, Nakamura T (2008) Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab 26:93–100

Article  PubMed  CAS  Google Scholar 

Khosla S, Samakkarnthai P, Monroe DG, Farr JN (2021) Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus. Nat Rev Endocrinol 17:685–697

Article  PubMed  PubMed Central  CAS  Google Scholar 

Vaculik J, Braun M, Dungl P, Pavelka K, Stepan JJ (2016) Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis. BMC Musculoskelet Disord 17:308

Article  PubMed  PubMed Central  Google Scholar 

Odetti P, Rossi S, Monacelli F, Poggi A, Cirnigliaro M, Federici M, Federici A (2005) Advanced glycation end products and bone loss during aging. Ann N Y Acad Sci 1043:710–717

Article  PubMed  CAS  Google Scholar 

Vavanikunnel J, Sewing L, Triantafyllidou M, Steighardt A, Baumann S, Egger A, Grize L, Felix B, Kraenzlin M, Henzen C, Meier C (2022) Determinants of low bone turnover in Type 2 diabetes-the role of PTH. Calcif Tissue Int 111:587–596

Article  PubMed  PubMed Central  CAS  Google Scholar 

Sewing L, Potasso L, Baumann S, Schenk D, Gazozcu F, Lippuner K, Kraenzlin M, Zysset P, Meier C (2022) Bone microarchitecture and strength in long-standing type 1 diabetes. J Bone Miner Res 37:837–847

Article  PubMed  CAS  Google Scholar 

Piccoli A, Cannata F, Strollo R, Pedone C, Leanza G, Russo F, Greto V, Isgro C, Quattrocchi CC, Massaroni C, Silvestri S, Vadala G, Bisogno T, Denaro V, Pozzilli P, Tang SY, Silva MJ, Conte C, Papalia R, Maccarrone M, Napoli N (2020) Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes. J Bone Miner Res 35:2415–2422

Article  PubMed  CAS  Google Scholar 

Meier C, Eastell R, Pierroz DD, Lane NE, Al-Daghri N, Suzuki A, Napoli N, Mithal A, Chakhtoura M, Fuleihan GE, Ferrari S (2023) Biochemical markers of bone fragility in patients with diabetes. J Clin Endocrinol Metab 108:923–936

Article  Google Scholar 

Feng Z, Zhu L, Wu J (2020) RAGE signalling in obesity and diabetes: focus on the adipose tissue macrophage. Adipocyte 9:563–566

Article  PubMed  PubMed Central  CAS  Google Scholar 

Yan SF, Ramasamy R, Schmidt AM (2010) The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature. Circ Res 106:842–853

Article  PubMed  PubMed Central  CAS  Google Scholar 

Stephen SJ, Bailey S, D’Erminio DN, Krishnamoorthy D, Iatridis JC, Vashishth D (2022) Bone matrix quality in a developing high-fat diet mouse model is altered by RAGE deletion. Bone 162:116470

Article  PubMed  PubMed Central  CAS  Google Scholar 

Forster A, Kuhne Y, Henle T (2005) Studies on absorption and elimination of dietary maillard reaction products. Ann N Y Acad Sci 1043:474–481

Article  PubMed  Google Scholar 

Uribarri J, Woodruff S, Goodman S, Cai W, Chen X, Pyzik R, Yong A, Striker GE, Vlassara H (2010) Advanced glycation end products in foods and a practical guide to